Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Aimei Health Technology Co., Ltd.: Amended Article 35.2 of the Articles of Association to extend the business combination deadline from 24 to 36 months after the IPO, i.e., to December 6, 2026 (effective 2025-11-26).
- Change
- charter amendment
- Effective
- 2025-11-26
Exact text from the filing
Article 35.2 of the Amended and Restated Articles of Association of the Company, as in effect immediately prior to the Extraordinary General Meeting, was amended and restated to essentially extend the date by which the Company has to consummate a business combination from 24 months from the date of the Company’s initial public offering (namely, December 6, 2025) to 36 months from the date of the Company’s initial public offering (namely, December 6, 2026).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Aimei Health Technology Co., Ltd. amended Trust Agreement Amendment with Continental Stock Transfer & Trust Company.
- Action
- amendment
- Counterparty
- Continental Stock Transfer & Trust Company
Exact text from the filing
Trust Agreement Amendment As approved by its shareholders at the Extraordinary General Meeting (defined below), Aimei Health Technology Co., Ltd (the “ Company ”) entered into an amendment (the “ Trust Agreement Amendment ”) to the Investment Management Trust Agreement, dated December 1, 2023 (the “ Trust Agreement ”), with Continental Stock Transfer & Trust Company, as trustee (“ Trustee ”).
View on SEC.gov